Publication: Aglepristone decreases proliferation in progesterone receptor-positive canine mammary carcinomas
Aglepristone decreases proliferation in progesterone receptor-positive canine mammary carcinomas
Date
Date
Date
Citations
Guil-Luna, S., Sánchez-Céspedes, R., Millán, Y., De Andrés, F. J., Rollón, E., Domingo, V., Guscetti, F., & Martín de Las Mulas, J. (2011). Aglepristone decreases proliferation in progesterone receptor-positive canine mammary carcinomas. Journal of Veterinary Internal Medicine, 25, 518–523. https://doi.org/10.1111/j.1939-1676.2011.0723.x
Abstract
Abstract
Abstract
BACKGROUND:
Progesterone receptor (PR) antagonist aglepristone (RU534) has been used successfully for pregnancy termination and therapy of pyometra, vaginal tumors, and mammary hyperplasia in bitches and queens. All of these conditions share with canine mammary carcinomas the expression of PR. OBJECTIVES:
To study the effect of RU534 on proliferation and apoptosis in canine mammary carcinomas in relation to PR expression. ANIMALS:
Twenty-seven nonspayed bitches with mammary carcinomas were treated with either 2 doses of 20 mg/kg RU
Metrics
Views
Additional indexing
Creators (Authors)
Journal/Series Title
Journal/Series Title
Journal/Series Title
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
In collections
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Publisher DOI
Metrics
Views
Citations
Guil-Luna, S., Sánchez-Céspedes, R., Millán, Y., De Andrés, F. J., Rollón, E., Domingo, V., Guscetti, F., & Martín de Las Mulas, J. (2011). Aglepristone decreases proliferation in progesterone receptor-positive canine mammary carcinomas. Journal of Veterinary Internal Medicine, 25, 518–523. https://doi.org/10.1111/j.1939-1676.2011.0723.x